Methods for the Production of Recombinant Heparosan, a Critical Heparin Precursor, from Nonpathogenic E. coli Strains.

Roy, Anindita; Garg, Varun; Mehta, Sai K; Rossi, Alessandro; Balagurunathan, Kuberan

Roy, Anindita; Garg, Varun; Mehta, Sai K; Rossi, Alessandro; Balagurunathan, Kuberan.

Afiliación

Roy A; Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT, USA.
Garg V; Department of Biology, University of Utah, Salt Lake City, UT, USA.
Mehta SK; Department of Bioengineering, University of Utah, Salt Lake City, UT, USA.
Rossi A; Department of Biology, University of Utah, Salt Lake City, UT, USA.
Balagurunathan K; Department of Bioengineering, University of Utah, Salt Lake City, UT, USA.

Methods Mol Biol ; 2303: 151-161, 2022.

Article en En | MEDLINE | ID: mdl-34626377

Asunto(s)

Escherichia coli; Animales; Anticoagulantes; Bovinos; Disacáridos; Escherichia coli/genética; Heparina; Porcinos

Palabras clave

Anticoagulants; Heparan sulfate; Heparin; Nonpathogenic strains; Recombinant heparosan

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Escherichia coli Límite: Animals Idioma: En Revista: Methods Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google